Core Insights - Futures for major indexes, including the Dow Jones industrial average, rose slightly early Monday, indicating a positive market sentiment [1] - Alphabet (GOOGL) continues to experience a rally driven by its advancements in artificial intelligence [1] - Novo Nordisk (NVO) shares fell significantly after its Ozempic pill failed to demonstrate effectiveness in slowing Alzheimer's progression [1] - Eli Lilly (LLY) saw a slight decline, while Biogen (BIIB) experienced a notable increase in its stock price [1] Company Summaries - **Alphabet (GOOGL)**: The company is benefiting from its ongoing efforts in artificial intelligence, contributing to a rally in its stock price [1] - **Novo Nordisk (NVO)**: The company's stock tumbled due to disappointing results from its Ozempic pill in relation to Alzheimer's treatment [1] - **Eli Lilly (LLY)**: The stock edged lower, reflecting market reactions to recent developments [1] - **Biogen (BIIB)**: The company saw a jump in its stock price, indicating positive market sentiment or news [1]